1342836-25-2Relevant articles and documents
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
-
Paragraph 0155-0157, (2013/03/26)
The disclosure relates to compounds of formula I: wherein the groups R1, R2, R3, R4, R5 and X are as defined in the disclosure, having antithrombotic activity, which in particular inhibits the protease-activated receptor 1 (PAR1). The disclosure further relates to methods for producing the same and to the use thereof as a pharmaceutical product.